e-Drug3D

1345

NANDROLONE PHENPROPIONATE

DISCONTINUED


INN
NANDROLONE PHENPROPIONATE

(has an active metabolite)

cas 62-90-8
CLASS

HORMONES
ANDROGENIC
AGONIST
ANABOLIC STEROID

ROUTE (list)

INJECTION

ATC code

A14AB01
S01XA11

PK parameters

Target

TARGET ANDROGEN RECEPTOR (AR)

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file Estr-4-en-3-one, 17-(1-oxo-3-phenylpropoxy)-, (17.beta.)-

Formula:
C27H34O3

Calculated chemical properties:

MW 406.54
NB_atoms 30
XLogP 5.67
PSA 41.545
NB_HD 0
NB_HA 3
fsp3 0.63
Lipinski(0=no;1=yes) 0

FDA
NDA 086386 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 087488 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089297 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089298 (pdf not found) INN (NANDROLONE PHENPROPIONATE) NANDROLONE PHENPROPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 011891 (pdf not found) INN (NANDROLONE PHENPROPIONATE) DURABOLIN (ORGANON USA INC) APPROVAL= AP YEAR= 1959 NEWMOLECULARENTITY DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL